Kallyope

Biotechnology Research • Manhattan, New York, United States • 51-100 Employees

Company overview

Headquarters	430 E. 29th Street, New York, New York 10016, US
Phone number	+19083776454
Website	kallyope.com
NAICS	541714
SIC	873
Keywords	Biotechnology, Pharmaceuticals, Neurology, Migraine, Metabolism, Gastrointestinal Disease
Employees	51-100
Socials

Key Contacts at Kallyope

David Ricardo López

Senior Director, Head Of Operations

Daniel Boisvert

Director, Clinical Operations

Anna Arreglado

Sr. Director, Head Of Data Management

Eugen Mesaros

Director

David Wang

Senior Director, Head Of Clinical Program And Portfolio

Justine Kupferman

Director, Neuroscience

Robert Barretto

Senior Director, Bd & Competitive Intelligence

Kallyope Email Formats

Kallyope uses 5 email formats. The most common is {first initial} (e.g., j@kallyope.com), used 61.5% of the time.

Format	Example	Percentage
{first initial}	j@kallyope.com	61.5%
{first initial}.{last name}	j.doe@kallyope.com	23.1%
{first name}.{last name}	john.doe@kallyope.com	7.7%
{first name}	john@kallyope.com	3.8%
{last name}	doe@kallyope.com	1.9%

About Kallyope

At Kallyope, we focus on big health challenges that matter to patients and families. We aim to discover and develop effective, easy to use, and well-tolerated oral agents addressing metabolic, neurological, and gastrointestinal diseases. Inside every human body is a complex, unexplored network of metabolic, neurological, and gastrointestinal interconnections. Our scientists are unlocking the mysteries of this network to develop oral therapies for obesity and diabetes; neurological disorders, including migraine; and gastrointestinal disease, including celiac disease. Based in New York City, we are home to some of the world’s most intrepid scientific minds from the world’s top institutions, working alongside a seasoned team with a proven track record of success in drug discovery and development. Together, we are leveraging multiple sophisticated technologies and internally-developed capabilities to bring fundamentally new solutions to some of the most pressing unmet needs in human health.

Kallyope revenue & valuation

Annual revenue	$7,000,000
Revenue per employee	$100,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$22,400,000
Total funding	$8,199,999